An in-house comparative study was performed to demonstrate the equivalence of the Cardiolipin IgA ELISA test system to another commercially available Cardiolipin IgA ELISA test system. Performance was evaluated using 260 specimens as described in Table 1 below. The results of the investigation have been summarized in Table 2 below.
Table 1. Summary of Clinical Specimens

Table 2: Calculation of Relative Sensitivity, Specificity, and Agreement Commercial Cardiolipin IgA Results

Relative Sensitivity = 34/36 = 94.4%
95% Confidence Interval** = 87.0 to 100%
Relative Specificity: = 154/200 = 77.0%
95% Confidence Interval** = 71.2 to 82.8%
Relative Agreement = 188/236 = 80.0%
95% Confidence Interval** = 74.5 to 85.5%
**95% confidence intervals calculated using the exact method.